World wide shipping
Medicines from all over the world
We will help you find any drug in 24 hours
Prices for medicines are presented for informational purposes only

Arzerra (ofatumumab) 1000 mg IV GLAXO UK

Article: G-7
In Stock
0 $
0 $
Description

testimony

  • Previously untreated chronic lymphocytic leukemia (CLL) Arzerra, together with chlorambucil or bendamustin, is indicated for the treatment of previously untreated CLL patients for whom fludarabine therapy cannot be used.
  • Refractory CLL Arzerra is indicated for the treatment of patients with CLL who have failed treatment with fludarabine and Alemtuzumab.
  • 820/100, 2340/1000 carats
  • azer, arzer, azar
Features
  • Commercial name:
    Arzerra
  • Сhemical name:
    ofatumumab
  • Dosage:
    1000 mg
  • Release form:
    Ampoule
  • Виробник:
    Glaxo, великобритания
Reviews
No reviews yet
Write Review
Name*
Email
Write a Review*